Catalyst

Granite and CEO Larkin Demonstrate Commitment to Accelerate Women’s Representation in Leadership

Retrieved on: 
화요일, 12월 14, 2021
Professional Services, Mining, Minerals, Consumer, Other Construction & Property, Residential Building & Real Estate, Natural Resources, Commercial Building & Real Estate, Construction & Property, Other Transport, Urban Planning, Women, Human Resources, Transport, Organization, GVA, Instagram, LinkedIn, Chief executive officer, Solution, Conduct, Change, History, Champion, NYSE, Core values, Industry, Woman, Pivotal, CEO, Goal, Man, Transport, Safety, Equity, Fortune, Leadership, Building material, Color, COVID-19, Twitter, Catalysis, DEI, Management, Granite, Facebook, Granite, Catalyst, GRANITE, CATALYST

Granite (NYSE:GVA) is proud to demonstrate its commitment to bringing more women into leadership as part of Catalyst CEO Champions for Change.

Key Points: 
  • Granite (NYSE:GVA) is proud to demonstrate its commitment to bringing more women into leadership as part of Catalyst CEO Champions for Change.
  • Granite CEO Kyle Larkin and more than 70 other Champion CEOs pledge to advance women across ethnic and racial groups into leadership roles.
  • The goals of Catalyst CEO Champions for Change align with our internal goal to increase women in leadership at Granite and in our industry.
  • Since Catalyst started collecting global data in 2018, Granite and the CEO Champion companies have collectively outpaced our global peers in the representation of women across the leadership pipeline.

Health Catalyst to Participate in Upcoming Investor Conference

Retrieved on: 
금요일, 7월 30, 2021
Canaccord Genuity, Catalyst, Service companies

SALT LAKE CITY, July 30, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, CFO, and Adam Brown, SVP of Investor Relations and FP&A, will participate in the 41st Annual Canaccord Genuity Growth Stock Conference including a fireside chat presentation on Wednesday, August 11, 2021 at 2:00 p.m.

Key Points: 
  • SALT LAKE CITY, July 30, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, CFO, and Adam Brown, SVP of Investor Relations and FP&A, will participate in the 41st Annual Canaccord Genuity Growth Stock Conference including a fireside chat presentation on Wednesday, August 11, 2021 at 2:00 p.m.
  • Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement.
  • Health Catalyst envisions a future in which all healthcare decisions are data informed.
  • Health Catalyst Investor Relations Contact:

Health Catalyst to Announce Second Quarter 2021 Operating Results and Host Conference Call on Thursday, August 5, 2021

Retrieved on: 
화요일, 7월 27, 2021
Catalyst

SALT LAKE CITY, July 27, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2021 second quarter operating results on Thursday, August 5, 2021, after market close.

Key Points: 
  • SALT LAKE CITY, July 27, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2021 second quarter operating results on Thursday, August 5, 2021, after market close.
  • In conjunction, the company will host a conference call to review the results at 5 p.m. E.T.
  • The conference call can be accessed by dialing 1-800-708-4539 for U.S. participants, or 1-847-619-6396 for international participants, and referencing participant code 50199342.
  • Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement.

Urban Catalyst Submits Formal Entitlements for Icon/Echo Towers in Downtown San Jose

Retrieved on: 
화요일, 7월 27, 2021
Architecture, Commercial Building & Real Estate, Construction & Property, Finance, Professional services, Urban planning, REIT, Residential Building & Real Estate, Geography of California, California, Downtown San Jose, San Jose, California, Silicon Valley, Cities in the United States, Catalyst, Santa Clara station, Downtown San José station, Santa Clara, California

The transit-oriented development is part of the federal Opportunity Zone tax relief program, and Urban Catalyst--a Qualified Opportunity Zone Fund--is currently accepting investments for the project.

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210727005172/en/
    Urban Catalyst Submits Formal Entitlements for Icon/Echo Towers in Downtown San Jose (Photo: Business Wire)
    Located at 147 E Santa Clara Street in the heart of downtown, Icon/Echo will create more than 300 multifamily apartment units and 420,000 square feet of Class-A office space.
  • Building high-density development near transit is Urban Planning 101, said Erik Hayden, Founder and CEO of Urban Catalyst.
  • Urban Catalyst has purchased two of the four parcels needed for the development and is under contract to purchase the remaining two.
  • Urban Catalyst is focused on ground-up development projects in downtown San Jose.

Family Equality Calls For Unity This Parents' Day

Retrieved on: 
금요일, 7월 23, 2021
Catalyst

Developed alongside creative agencies TBWA \ Chiat \ Day New York and Furlined , Family Equality has created Love, Lawyers & The Government , a warm and endearing short film intended to serve as a catalyst for this continued movement.

Key Points: 
  • Developed alongside creative agencies TBWA \ Chiat \ Day New York and Furlined , Family Equality has created Love, Lawyers & The Government , a warm and endearing short film intended to serve as a catalyst for this continued movement.
  • To join Family Equality in garnering support for nationwide protections for LGBTQ+ people and their families, please visit action.familyequality.org .
  • Family Equality advances legal and lived equality for LGBTQ+ families, and for those who wish to form them, through building community, changing hearts and minds, and driving policy change.
  • Family Equality believes every LGBTQ+ person should have the right and opportunity to form and sustain a loving family, regardless of who they are or where they live.

Kenneth C. Frazier, Merck Executive Chairman and Former CEO, Joins General Catalyst as Chairman of Its Health Assurance Initiatives

Retrieved on: 
수요일, 7월 21, 2021
Finance, Investment, Money, Entrepreneurship, Kenneth Frazier, General Catalyst, Venture capital, Kenneth Chenault, Frazier, Catalyst

In his new role at GC, Frazier will help guide the strategy of the firm’s healthcare initiatives in an effort to shift the paradigm from a “sick care” system to a resilient, proactive Health Assurance system -- designed to help people stay well, bend the cost curve through innovation, and make quality care more affordable and more accessible to all.

Key Points: 
  • NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) -- The venture capital firm General Catalyst announced today that Kenneth C. Frazier, Merck Executive Chairman and former CEO, will be joining the firm in the newly created role of Chairman, Health Assurance Initiatives.
  • Under his leadership, Merck researchers made historic breakthroughs in immuno-oncology and other fields of medicine that have transformed clinical practice and greatlyimproved patient outcomes.
  • The connection between General Catalyst and Ken Frazier is his long-standing friendship with GC's chairman and managing director, Ken Chenault, with whom Frazier attended law school.
  • General Catalyst is a venture capital firm that invests in powerful, positive change that endures for our entrepreneurs, our investors, our people, and society.

Catalyst Updates Eligibility Criteria for Its Preeminent Catalyst Award

Retrieved on: 
수요일, 7월 21, 2021
Catalyst, Hariton, Businesspeople

NEW YORK, July 21, 2021 /PRNewswire/ --  The Catalyst Award—Catalyst's coveted signature recognition of diversity, equity, and inclusion (DEI) honoring innovative and impactful organizational initiatives that accelerate the advancement of women through workplace inclusion—is updating its criteria.

Key Points: 
  • "The Catalyst Award reflects progress, not perfection, and holds companies to a standard of excellence.
  • Today we're raising our standards to keep the Catalyst Award at the forefront of diversity, equity, and inclusion," said Catalyst President & CEO Lorraine Hariton .
  • Given annually to workplace initiatives globally since 1987, the Catalyst Award has recognized 103 initiatives from 91 organizations .Catalyst Award-winning initiatives must meet a minimum standard of excellence and include data to assess impact.
  • The application for the 2023 Award will be posted on the Catalyst website in early 2022.

Catalyst Updates Eligibility Criteria for Its Preeminent Catalyst Award

Retrieved on: 
수요일, 7월 21, 2021
Catalyst, Hariton, Businesspeople

NEW YORK, July 21, 2021 /PRNewswire/ --  The Catalyst Award—Catalyst's coveted signature recognition of diversity, equity, and inclusion (DEI) honoring innovative and impactful organizational initiatives that accelerate the advancement of women through workplace inclusion—is updating its criteria.

Key Points: 
  • "The Catalyst Award reflects progress, not perfection, and holds companies to a standard of excellence.
  • Today we're raising our standards to keep the Catalyst Award at the forefront of diversity, equity, and inclusion," said Catalyst President & CEO Lorraine Hariton .
  • Given annually to workplace initiatives globally since 1987, the Catalyst Award has recognized 103 initiatives from 91 organizations .Catalyst Award-winning initiatives must meet a minimum standard of excellence and include data to assess impact.
  • The application for the 2023 Award will be posted on the Catalyst website in early 2022.

Catalyst Biosciences Presents Four Posters at the International Society for Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress

Retrieved on: 
월요일, 7월 19, 2021
Blood, International Society on Thrombosis and Haemostasis, Pharmacokinetics, Thrombosis and Haemostasis, Catalyst, Life sciences, Health sciences, Articles

SOUTH SAN FRANCISCO, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today presented four posters at the International Society for Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress, being held July 17-21, 2021.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today presented four posters at the International Society for Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress, being held July 17-21, 2021.
  • The objective of the study was to conduct simulations using a MarzAA-specific, population pharmacokinetic (PK) model in a large population following different dose levels of MarzAA.
  • A copy of the presentation materials can be accessed on the Scientific Presentations and Publicationssection of the Catalyst website.
  • The Company does not assume any obligation to update any forward-looking statements, except as required by law.

Catalyst Biosciences Announces Key Leadership Changes in its Ongoing Transition to an Integrated Protease Medicines Company

Retrieved on: 
수요일, 7월 14, 2021
Catalyst, Protease

Howard Levy, M.B.B.Ch, Ph.D., M.M.M., chief medical officer, announced his plan to retire and transition to a senior clinical advisor role to Catalyst.

Key Points: 
  • Howard Levy, M.B.B.Ch, Ph.D., M.M.M., chief medical officer, announced his plan to retire and transition to a senior clinical advisor role to Catalyst.
  • Id like to thank Nassim and the entire Catalyst family for their collaboration and support over my years of service.
  • I look forward to Catalyst continuing to advance MarzAA and DalcA so that patients can have an improved quality of life, said Dr. Levy.
  • During his tenure at Catalyst, he has been instrumental in building our protease engineering platform and our hemophilia and complement programs.